Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788249 | SCV000927300 | uncertain significance | not provided | 2017-06-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001043894 | SCV001207663 | uncertain significance | Aicardi Goutieres syndrome 3 | 2019-12-03 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine with isoleucine at codon 59 of the RNASEH2C protein (p.Leu59Ile). The leucine residue is moderately conserved and there is a small physicochemical difference between leucine and isoleucine. This variant is present in population databases (rs764887792, ExAC 0.005%). This variant has not been reported in the literature in individuals with RNASEH2C-related conditions. ClinVar contains an entry for this variant (Variation ID: 636423). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |